Search for: "Schering-Plough Corporation"
Results 41 - 60
of 100
Sort by Relevance
|
Sort by Date
2 Oct 2010, 8:43 am
Peter Rost is a former Pfizer Marketing Vice President providing services as an expert witness on pharmaceutical marketing and consulting services on corporate therapeutics and ethics guidelines. [read post]
20 Aug 2010, 12:56 pm
Significant Case Studies Give You The Chance To Learn About New Partnerships and New Agreements In The Industry * BMS and Allergan * Merck and Schering-Plough * Sanofi-Aventis and Intelliject * J&J and Takeda * Eli Lilly and Kowa Pharmaceuticals * Eli Lilly and Incyte Corporation The Perfect Pitch: Biotech Investment Challenge In this groundbreaking session, Biotech companies will have the chance to present your new research and new therapies (either in early stages or… [read post]
14 Jul 2010, 7:53 am
Schering-Plough Healthcare Products Inc. v. [read post]
7 Jul 2010, 8:07 am
Schering-Plough Corp., 367 N.J. [read post]
25 Apr 2010, 5:52 pm
In 2005, in Schering-Plough Corp. v. [read post]
23 Apr 2010, 9:29 am
Plaintiffs Schering-Plough HealthCare Products, Inc. [read post]
20 Apr 2010, 5:07 pm
., and Schering-Plough Corporation, not only knew about the potential side effects associated with NUVARING®, but concealed those risks from the public, including the FDA during the approval process. [read post]
14 Apr 2010, 1:05 pm
Clark's money is nothing compared to the compensation packages of execs at Schering-Plough, which Merck bought last year, who apparently, "walked away with massive pay packages, thanks to 'golden handshake' deals that were part of their pay agreements with Schering. [read post]
14 Apr 2010, 1:05 pm
Clark's money is nothing compared to the compensation packages of execs at Schering-Plough, which Merck bought last year, who apparently, "walked away with massive pay packages, thanks to 'golden handshake' deals that were part of their pay agreements with Schering. [read post]
31 Mar 2010, 1:51 am
Judge Approves Zero-Dollar Settlement of Class Action Over Merck Merger New Jersey Law Journal A class action suit over the merger of drug giants Merck and Schering-Plough has ended in a settlement that pays nothing to the class but $3.5 million in fees to class counsel. [read post]
23 Feb 2010, 6:16 am
Editor’s Note: John Olson is a founding partner of Gibson, Dunn & Crutcher’s Washington, D.C. office and a visiting professor at the Georgetown Law Center. [read post]
15 Jan 2010, 10:49 am
This means looking at "the facts and the law and the witnesses and the documents" according to PD Villarreal, the head of litigation for Schering-Plough. [read post]
8 Jan 2010, 12:43 am
$165 Million Schering-Plough Class Action Settlement Includes $37 Million in Fees New Jersey Law Journal A federal judge has approved a $165 million settlement of a securities fraud suit against Schering-Plough -- one of the five largest securities class action recoveries in the District of New Jersey -- that includes more than $37 million for the plaintiffs lawyers. [read post]
31 Dec 2009, 7:19 am
’s proposed $68 billion acquisition of Wyeth, and Schering-Plough Corporation was permitted to proceed with its proposed $41.1 billion acquisition of Merck & Co. [read post]
28 Dec 2009, 7:57 am
Schering-Plough recently merged with Merck, and is now known as Merck & Co.California's $21.3 million agreement is one of three settlements negotiated with Schering-Plough, collectively totaling $69 million, over falsely inflated drug prices. [read post]
23 Dec 2009, 8:39 am
" According to the NFL website sponsors include Burger King, Campbell's, Canon USA, Coors Brewing, Dairy Management Inc., FedEx, Frito-Lay, Gatorade, General Motors, IBM, Masterfoods, MBNA, Motorola, News America, PepsiCo: Diet Pepsi, PepsiCo: Tropicana, Procter & Gamble (Prilosec), Schering-Plough (Levitra), Southwest Airlines, Sprint, Visa. [read post]
23 Dec 2009, 6:06 am
In In Re: Schering Plough Corporation ERISA Litigation, No. 08-4814 (3rd Cir. 2009), the plaintiff, Michele Wendell, is a former employee of Schering-Plough Corporation ("Schering-Plough") who participated in the Schering-Plough Corporation Employees' Savings Plan (the "Plan"). [read post]
16 Dec 2009, 2:51 pm
At the time Schering-Plough announced its acquisition of Merck, however, Schering-Plough was in the process of licensing its own, newly developed NK 1 receptor antagonist for nausea and vomiting, rolapitant, to a third party. [read post]
8 Dec 2009, 7:00 pm
EVP and general counsel, Schering-Plough. [read post]
8 Dec 2009, 9:08 am
Sabatino Jr., former EVP and general counsel, Schering-Plough Michael F. [read post]
